Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

s (b) 3,754 - 3,754 -

Total purchase accounting

adjustments, pre-tax 4,080 - 4,080 -

Income tax benefit 89 - 89 -

Total purchase

accounting

adjustments $ 3,991 $- $ 3,991 $-

Acquisition-related items:

Acquisition-related

(gains)/losses on

currency-related and

interest-related items (c) $ (255) $- $ (537) $-

Integration-related

activities (d) 52 - 84 -

Total acquisition-related

items, pre-tax (203) - (453) -

Income tax benefit 2 - 2 -

Total acquisition-

related items $ (205) $- $ (455) $-

Other specified items:

Manufacturing changes

announced June 1, 2006 (e) $- $57 $- $ 248

Upfront R&D payments (b) 21 15 197 15

Change in accounting

principle (f) - - - (22)

Total other specified

items, pre-tax 21 72 197 241

Income tax benefit 1 - 1 -

Total other

specified items $20 $72 $196 $241

Total purchase

accounting adjustments,

acquisition-related

items and other

specified items $ 3,806 $72 $3,732 $241

(a) Included in cost of sales

(b) Included in research and development

(c) Included in other (income)/expense, net

(d) Included in special and acquisition-related charges

(e) Included in cost of sales an
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...Taxpayer Bill of Rights proposal are aiming direct...venue limits on state, county, and municipal gover...ss climate. , ,TABOR, they say, places economic de... in jeopardy. , ,Based in part on Colorado,s TABOR...ent would be handcuffed should the measure be enac...
...ay be a flat state, but at BIO 2006 in Chicago it,... hope will draw people from across the exhibition ...wer with lighted displays, which Forward Wisconsi... in Madison before the April 9-12 event. , ,Jan Al...sconsin, is coordinating company involvement in th...
...n as an emerging biotechnology hot spot will be fu...epresented at one of the world,s premier biotechno...e hope. , ,Wisconsin attendees will make up 1.5 pe...ogy Industry Organization,s International Conventi...ormick Place Convention Center. That,s more than m...
... a day when the fledgling Biomedical Technology Al...lity, receiving $500,000 from the Wisconsin Dept. ...s, it was an anecdote from a chemistry professor t...r collaboration between academic researchers. , ,I...stitutional partnerships that are expected to resu...
Other Biology Technology:Critics say tax limits could handcuff tech investment 2Critics say tax limits could handcuff tech investment 3Critics say tax limits could handcuff tech investment 4Critics say tax limits could handcuff tech investment 5State pavilion goes for height, style at BIO expo 2Wisconsin to show up at BIO in numbers 2Wisconsin to show up at BIO in numbers 3Alliance looks to create the right chemistry in SE Wisconsin 2Alliance looks to create the right chemistry in SE Wisconsin 3
(Date:10/3/2008)...he appointment of Esin Gulari, dean of the College... to serve on the National Science Board (NSB). Pre...t along with six other distinguished scientists. ,...st and an engineer," said Gulari. "On the NSB, I w...on a national level. I hope that my participation ...
(Date:10/3/2008)...idies of cellulosic ethanol production and use hav...o an international group of scientists which inclu...d Oklahoma State University. , The 23-member gr...ce-based policy to address this global issue for t...ce, OU botany professor, and Michael Palmer, OSU b...
(Date:10/3/2008)...conspicuous traits produced by melanin pigments (f... some birds and fishes). These traits are used as ...ibute to increase the mating opportunities. Howeve...ds on the fact that they transmit honest informati...only assured by the fact that producing or maintai...
(Date:10/3/2008)...posture and exercise power is due to humans, evolu...iversity of New South Wales (UNSW). , Prehistori...what is perceived as their "turf" and ostracising ...onplace in everyday work situations than many of u...was carried out in hospitals. , "This tribal cul...
Breaking Biology News(10 mins):US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board 2Oklahoma researchers support biodiversity in biofuels production 2Traits produced by melanin may signal the bearer's capacity to combat free radicals 2Why your boss is white, middle-class and a show-off 2Symposium on energy research highlights future challenges opportunities 2819 1Symposium on energy research highlights future challenges opportunities 2819 2Manufactured Buckyballs dont harm microbes that clean the environment 2817 1Manufactured Buckyballs dont harm microbes that clean the environment 2817 2Manufactured Buckyballs dont harm microbes that clean the environment 2817 3Manufactured Buckyballs dont harm microbes that clean the environment 2817 4Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 1Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 2Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 3Lupus Webchat April 9 Features Ask the Doctor Open Forum 16274 1Lupus Webchat April 9 Features Ask the Doctor Open Forum 16274 2
...d smoking have a high rate of co-occurrence in the...e co-morbidity of alcoholism and smoking among Ame... Clinical & Experimental Research , researcher...g Plains American Indians, as well as the influenc...ional polymorphism called Val158Met may have on th...
...h self-assembly technique for growing replacement ...ntire articular surface of knees damaged by arthri... Musculoskeletal Bioengineering Laboratory, is des... Engineering. , "This has significant ramification...rst time, about the potential treatment of entire ...
... microbiology textbook aimed at undergraduate stud... Written by eminent scientists with practical te...Microbe, will engage students in the learning proc...ique perspective of the field. , "Our working plan...gh facts have a tendency to creep in," says Moseli...
...s have just learned another lesson from nature. Af...eate self-medications, such as anti-fungal agents,...entists already knew that a particular enzyme was ...oncoctions to generate a large family of medically...ducts. The question was, how do they do it? , Che...
Other Biology News:Alcoholism, smoking and genetics among Plains American Indians 2Alcoholism, smoking and genetics among Plains American Indians 3Rice bioengineers pioneer techniques for knee repair 2Microbiology text tells stories, offers online resources 2MIT chemist discovers secret behind nature's medicines 2